Dr. Thomas Shrader

BTIG Research

Recent Articles about Alto Neuroscience Inc.

What Do Analysts Think About the Biopharma Set on Transforming Psychiatry 04/09/2026

Alto Neuroscience Inc. (ANRO:NYSE) is a clinical-stage biopharmaceutical company focused on transforming psychiatry through novel drug candidates.

How Do Analysts Rate This Biopharma Targeting Psychiatric Disorders 11/20/2025

Alto Neuroscience Inc. (ANRO:NYSE) is developing drug candidates for psychiatric and neurological disorders, utilizing a precision approach rather than a one-size-fits-all method. Read to find out how analysts rate this company.